Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI6469 in Advanced Solid Tumors and DLBCL
NCT02205333Phase 2Terminated
- Sponsor
- MedImmune
- Start
- Aug 2014
- Primary completion
- Apr 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of medi-6469 in solid tumor (advanced stage), diffuse large B-cell lymphoma (DLBCL), sponsored by MedImmune. Started Aug 2014; status: terminated.
02
Drugs
medi-6469
03
Conditions
solid tumor (advanced stage)diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT02205333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02205333.